Results of this study suggest that Pin1 down-regulation could be a potential approach in obesity-related dysfunctions, such as high blood pressure, diabetes, non-alcoholic steatohepatitis. The gene discussed is PIN1; the disease is metabolic dysfunction-associated steatohepatitis.